Showing results (191-200 of 288) with videos related to
Sort By:
Pageof 29
The Journal of Allergy and Clinical Immunology. in Practice|May 31, 2022
Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic EsophagitisMichael E Wechsler, Amy D Klion, Pierluigi Paggiaro, et al.The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccinesMichael E Wechsler, Adelmir Souza-Machado, Christine Xu, et al.American Journal of Respiratory and Critical Care Medicine|November 6, 2015
Vitamin D Supplementation and the Risk of Colds in Patients with AsthmaLoren C Denlinger, Tonya S King, Juan Carlos Cardet, et al.Contemporary Clinical Trials|December 30, 2018
Adapting clinical trial design to maintain meaningful outcomes during a multicenter asthma trial in the precision medicine eraChristine A Sorkness, Tonya S King, Anne-Marie Dyer, et al.The Journal of Allergy and Clinical Immunology. in Practice|December 14, 2023
Association of Sputum Eosinophilia With Easily Measured Type-2 Inflammatory Biomarkers in Untreated Mild Persistent AsthmaRonina Covar, Stephen C Lazarus, Jerry A Krishnan, et al.Chest|February 26, 2022
Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE TrialLawrence D Sher, Michael E Wechsler, Klaus F Rabe, et al.The New England Journal of Medicine|May 18, 2017
KIT Inhibition by Imatinib in Patients with Severe Refractory AsthmaKatherine N Cahill, Howard R Katz, Jing Cui, et al.American Journal of Respiratory and Critical Care Medicine|August 28, 2014
Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthmaEmiko Ono, Stefanie Dutile, Shamsah Kazani, et al.Annals of the American Thoracic Society|November 18, 2021
Biomarkers to Predict Response to Inhaled Corticosteroids and Long-Acting Muscarinic Antagonists in Adolescents and Adults with Mild Persistent AsthmaJerry A Krishnan, Stephen C Lazarus, Kathryn V Blake, et al.The Journal of Allergy and Clinical Immunology|September 1, 2012
Workshop report from the National Institutes of Health Taskforce on the Research Needs of Eosinophil-Associated Diseases (TREAD)Bruce S Bochner, Wendy Book, William W Busse, et al.Pageof 29